Hans Moebius
Chief Medical Officer at Athira Pharma, Inc. (LONA)
Hans Moebius has filed 10 insider reports with the SEC since February 2021, as chief Medical Officer at Athira Pharma, Inc. (LONA). Hans Moebius made no open-market purchases or sales in the last 12 months. The latest filing, on January 8, 2024, reports grant or award at Athira Pharma, Inc. (LONA).
- Filings
- 10
- Companies
- 1
- Bought on market
- $45.2K
- Sold on market
- None
Companies where Hans Moebius is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Medical Officer | 91,482 | $45.2K | $3.02 | $2.02-33% | Jan 8, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Jan 4, 2024LONAMoebius Hans was granted 10,000 shares, increasing direct ownership by 12% to 91,482 unitsForm 4Grant or award
- Jun 2, 2023LONASEC Form 4 filed by Moebius HansForm 4Grant or awardExercise or conversion of a derivative
- Jan 19, 2023LONASEC Form 4 filed by Moebius HansForm 4Grant or award
- Nov 15, 2022+$16.4KLONASEC Form 4: Moebius Hans bought $16,442 worth of shares (5,000 units at $3.29), increasing direct ownership by 8% to 65,836 unitsForm 4Open-market purchase
- Oct 13, 2022LONASEC Form 4: Moebius Hans exercised 7,881 shares at a strike of $1.35, increasing direct ownership by 15% to 60,836 unitsForm 4Exercise or conversion of a derivative
- Jun 28, 2022+$28.8KLONASEC Form 4: Moebius Hans bought $28,800 worth of shares (10,000 units at $2.88), increasing direct ownership by 23% to 52,955 unitsForm 4Open-market purchase
- Jun 22, 2022LONASEC Form 4: Moebius Hans was granted 11,699 shares, increasing direct ownership by 37% to 42,955 unitsForm 4Grant or award
- Jan 18, 2022LONASEC Form 4: Moebius Hans was granted 829 shares, increasing direct ownership by 3% to 31,256 unitsForm 4Grant or award
- Jul 21, 2021LONASEC Form 4: MOEBIUS HANS was granted 2,055 units of Common Stock and exercised 28,372 units of Common Stock at a strike of $1.35Form 4Grant or awardExercise or conversion of a derivative
- Feb 18, 2021LONASEC Form 4 filed by Hans MoebiusForm 4Grant or award
Compare Hans Moebius with
- Hans Moebius vs Fred Callori1 shared
- Hans Moebius vs Natalie C. Holles1 shared
- Hans Moebius vs Peter B. Silverman1 shared
- Hans Moebius vs Michael A. Panzara1 shared
- Hans Moebius vs Kelly A Romano1 shared
- Hans Moebius vs Joseph Edelman1 shared
Other insiders at the same companies
- David J. PortmanLONA
- Perceptive Advisors LLCLONA
- Fred CalloriLONA
- Natalie C. HollesLONA
- Peter B. SilvermanLONA
- Michael A. PanzaraLONA
- Kelly A RomanoLONA
- Joseph EdelmanLONA
- James A JohnsonLONA
- Barbara KosaczLONA
- Grant PickeringLONA
- Kevin ChurchLONA
- Martin Javier SanLONA
- John M Fluke JrLONA
- Mark WorthingtonLONA
- Robert RenningerLONA
Questions about Hans Moebius
- What is Hans Moebius's role at Athira Pharma, Inc.?
- Hans Moebius reports to the SEC as chief Medical Officer at Athira Pharma, Inc. (LONA), according to the latest filing on January 8, 2024.
- How many shares does Hans Moebius own?
- After the latest filing that states it, Hans Moebius directly owned 91,482 shares of Athira Pharma, Inc. (LONA). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Hans Moebius bought or sold stock recently?
- The most recent open-market purchase was on November 15, 2022: bought 5,000 shares of Athira Pharma, Inc. (LONA) for $16.4K at an average of $3.29.
- How do I get alerts when Hans Moebius files?
- Follow Hans Moebius on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Hans Moebius (SEC CIK 0001822494). Totals count each trade once, skipping amendments whose original is on file, from Feb 22, 2021 on. View on SEC EDGAR · Get this as JSON